Development of Real-Time and Accelerated Dissolution Methods for a Long-Acting Levonorgestrel Intrauterine System

长效左炔诺孕酮宫内节育系统实时加速溶解方法的开发

基本信息

  • 批准号:
    9135219
  • 负责人:
  • 金额:
    $ 17万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-09-15 至 2020-08-31
  • 项目状态:
    已结题

项目摘要

ABSTRACT During the past few decades, long-acting drug products (such as intrauterine devices/systems and subdermal implants) have successfully delivered contraceptive steroids in a controlled manner over periods of years. Among these drug products, the levonorgestrel intrauterine system (IUS) is considered a highly effective and reversible contraception option and is preferred by women of all ages. Currently, there are three long-acting levonorgestrel IUSs on the U.S. market and several of these are about to come off patent. Consequently, generic equivalents of these products are expected to enter into the regulatory review and approval process in the near future. Therefore, it is crucial that appropriate in vitro performance testing methods are available to ensure product quality and safety and streamline the regulatory review process. In vitro release testing is an important tool that not only ensures product quality and consistent performance, but also assists in the product development and regulatory review processes. In vitro release testing has been recommended as part of the demonstration of bioequivalence between test and reference products in the approval of most generic drugs. However, at present, there is a lack of compendial or FDA recommended in vitro release methods available for the long-acting levonorgestrel IUSs and the information available in the literature is extremely limited. This has been a major obstacle to product development and regulatory review. Over the past 17 years, our laboratory has made considerable contributions to the development and validation of in vitro release methods (both real- time and accelerated) for long-acting complex parenteral drug products (such as microspheres, and implants). For example, an accelerated USP apparatus 4 method has been developed as a rapid quality control method with discriminatory ability for implant formulations. Most recently, in collaboration with the FDA, our laboratory has been developing appropriate in vitro release methods capable of detecting manufacturing differences and predicting in vivo performance for complex parenteral drug products (such as microspheres, in situ forming implants, as well as ophthalmic ointments). Building on the knowledge gained in these studies, it is now proposed to develop appropriate, robust in vitro release methods (both real-time and accelerated) that can discriminate levonorgestrel IUSs (that are qualitatively (Q1) and quantitatively (Q2) equivalent in inactive ingredients with manufacturing differences) and can predict their in vivo performance. An effort will be made to develop accelerated release method(s) using compendial dissolution apparatus. Mirena® has been chosen as the Reference List Drug (RLD) since it will be the first IUS to come off patent. A comprehensive understanding of the effect of manufacturing differences on critical physicochemical and mechanical properties of levonorgestrel IUSs and their in vitro and in vivo performance will be obtained. This research will facilitate the establishment of bioequivalence recommendations for generic levonorgestrel IUSs, which in turn will help provide the public with safe and effective generic products at reduced cost and in a timely fashion.
摘要 在过去几十年中,长效药物产品(如宫内避孕器/系统和皮下注射器) 植入物)已经成功地以受控的方式递送避孕类固醇多年。 在这些药物产品中,左炔诺孕酮子宫内系统(IUS)被认为是一种高效且 可逆的避孕选择,是所有年龄段女性的首选。目前,有三种长效 左炔诺孕酮宫内节育器在美国市场上,其中几个即将关闭专利。因此,委员会认为, 这些产品的仿制药预计将进入监管审查和批准程序, 不久的将来因此,至关重要的是,适当的体外性能测试方法可用于 确保产品质量和安全,并简化监管审查程序。体外释放测试是一项 一个重要的工具,不仅确保产品质量和一致的性能,而且还有助于产品 开发和监管审查流程。体外释放试验已被推荐作为 在大多数仿制药的批准中证明试验药物和参比药物之间的生物等效性。 然而,目前,缺乏药典或FDA推荐的可用于治疗的体外释放方法。 长效左炔诺孕酮IUS和文献中可用的信息非常有限。这 一直是产品开发和监管审查的主要障碍。17年来,我们的实验室 已经对体外释放方法的开发和验证做出了相当大的贡献(包括真实的- 时间和加速)用于长效复合胃肠外药物产品(如微球和植入物)。 例如,已开发了加速USP装置4方法作为快速质量控制方法 对植入物配方具有辨别能力。最近,我们的实验室与FDA合作, 一直在开发能够检测制造差异的适当体外释放方法, 预测复杂肠胃外药物产品(例如微球、原位形成 植入物以及眼用软膏)。在这些研究中获得的知识的基础上, 建议开发适当的、稳健的体外释放方法(实时和加速), 区分左炔诺孕酮IUS(定性(Q1)和定量(Q2)等同于无活性 具有制造差异的成分),并且可以预测它们的体内性能。将努力 使用药典溶出仪开发加速释放方法。曼月乐®已被选为 参考清单药物(RLD),因为它将是第一个IUS的专利。全面了解 制造差异对关键理化和机械性能的影响 将获得左炔诺孕酮IUS及其体外和体内性能。这项研究将有助于 建立通用左炔诺孕酮IUS的生物等效性建议,这反过来将有助于 以较低的成本和及时的方式向公众提供安全有效的非专利产品。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DIANE JANE BURGESS其他文献

DIANE JANE BURGESS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DIANE JANE BURGESS', 18)}}的其他基金

Needle-implantable sensor with multi-sensing elements for accurate glucose monitoring
具有多传感元件的针植入式传感器,用于精确监测血糖
  • 批准号:
    8903557
  • 财政年份:
    2015
  • 资助金额:
    $ 17万
  • 项目类别:
Development of Real-Time and Accelerated Dissolution Methods for a Long-Acting Levonorgestrel Intrauterine System
长效左炔诺孕酮宫内节育系统实时加速溶解方法的开发
  • 批准号:
    10166842
  • 财政年份:
    2015
  • 资助金额:
    $ 17万
  • 项目类别:
Development of Real-Time and Accelerated Dissolution Methods for a Long-Acting Levonorgestrel Intrauterine System
长效左炔诺孕酮宫内节育系统实时加速溶解方法的开发
  • 批准号:
    9060050
  • 财政年份:
    2015
  • 资助金额:
    $ 17万
  • 项目类别:
Development of Real-Time and Accelerated Dissolution Methods for a Long-Acting Levonorgestrel Intrauterine System
长效左炔诺孕酮宫内节育系统实时加速溶解方法的开发
  • 批准号:
    9338044
  • 财政年份:
    2015
  • 资助金额:
    $ 17万
  • 项目类别:
Development of Real-Time and Accelerated Dissolution Methods for a Long-Acting Levonorgestrel Intrauterine System
长效左炔诺孕酮宫内节育系统实时加速溶解方法的开发
  • 批准号:
    10686873
  • 财政年份:
    2015
  • 资助金额:
    $ 17万
  • 项目类别:
Development of Real-Time and Accelerated Dissolution Methods for a Long-Acting Levonorgestrel Intrauterine System
长效左炔诺孕酮宫内节育系统实时加速溶解方法的开发
  • 批准号:
    10477957
  • 财政年份:
    2015
  • 资助金额:
    $ 17万
  • 项目类别:
Evaluation and Development of Dissolution Testing Methods for Semisolid Ocular Drug Products
半固体眼科药品溶出度测试方法的评价和开发
  • 批准号:
    9131459
  • 财政年份:
    2014
  • 资助金额:
    $ 17万
  • 项目类别:
DISSOLUTION METHODS FOR PARENTERAL SUSTAINED RELEASE IMPLANT DRUG PRODUCTS
肠外缓释植入药物产品的溶出方法
  • 批准号:
    8843631
  • 财政年份:
    2014
  • 资助金额:
    $ 17万
  • 项目类别:
Evaluation and Development of Dissolution Testing Methods for Semisolid Ocular Drug Products
半固体眼科药品溶出度测试方法的评价和开发
  • 批准号:
    8844139
  • 财政年份:
    2014
  • 资助金额:
    $ 17万
  • 项目类别:
In vitro-In vivo Correlations of Parentral Microsphere Drug Products
肠外微球药物产品的体外-体内相关性
  • 批准号:
    9143363
  • 财政年份:
    2013
  • 资助金额:
    $ 17万
  • 项目类别:

相似国自然基金

Immuno-Real Time PCR法精确定量血清MG7抗原及在早期胃癌预警中的价值
  • 批准号:
    30600737
  • 批准年份:
    2006
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
无色ReAl3(BO3)4(Re=Y,Lu)系列晶体紫外倍频性能与器件研究
  • 批准号:
    60608018
  • 批准年份:
    2006
  • 资助金额:
    28.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

NSF Convergence Accelerator Track L: Innovative chemical microsensor development for in situ, real-time monitoring of priority water pollutants to protect water quality
NSF Convergence Accelerator Track L:创新化学微传感器开发,用于对重点水污染物进行原位实时监测,以保护水质
  • 批准号:
    2344373
  • 财政年份:
    2024
  • 资助金额:
    $ 17万
  • 项目类别:
    Standard Grant
Further development of a unique dual-purpose real-time monitor of Tritium (Beta radiation) in Air & Tritium in Water at environmental levels.
进一步开发空气中氚(β辐射)的独特双用途实时监测仪
  • 批准号:
    10074646
  • 财政年份:
    2023
  • 资助金额:
    $ 17万
  • 项目类别:
    Collaborative R&D
Development of real-time dosimetry system for radiotherapy using deep learning
利用深度学习开发放射治疗实时剂量测定系统
  • 批准号:
    23K07109
  • 财政年份:
    2023
  • 资助金额:
    $ 17万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development and Optimization of a Digital AC-DC Electropenetrograph for Real-Time Recording of On-host Tick Feeding
用于实时记录宿主蜱摄食的数字交流-直流电渗透仪的开发和优化
  • 批准号:
    2304787
  • 财政年份:
    2023
  • 资助金额:
    $ 17万
  • 项目类别:
    Continuing Grant
Design and Development of a Near Real-Time Community Crowdsourced Resilience Information System for Enhancing Community Resilience in the Face of Flooding and other Extreme Events
设计和开发近实时社区众包抗灾信息系统,以增强社区面对洪水和其他极端事件的抗灾能力
  • 批准号:
    2325631
  • 财政年份:
    2023
  • 资助金额:
    $ 17万
  • 项目类别:
    Standard Grant
Development and validation of innovative, near real-time analytical tools to enable mitigation of contamination within cleanrooms of the UK spacecraft
开发和验证创新的近实时分析工具,以减轻英国航天器洁净室内的污染
  • 批准号:
    ST/X005356/1
  • 财政年份:
    2023
  • 资助金额:
    $ 17万
  • 项目类别:
    Training Grant
Motion-Resistant Background Subtraction Angiography with Deep Learning: Real-Time, Edge Hardware Implementation and Product Development
具有深度学习的抗运动背景减影血管造影:实时、边缘硬件实施和产品开发
  • 批准号:
    10602275
  • 财政年份:
    2023
  • 资助金额:
    $ 17万
  • 项目类别:
Development of solid-liquid interface total-reflection x-ray spectroscopy with the sensitivity of a few nm and its application to track reactions at solid-liquid interfaces in a real-time manner
几纳米灵敏度固液界面全反射X射线光谱仪的研制及其在实时跟踪固液界面反应中的应用
  • 批准号:
    23K11710
  • 财政年份:
    2023
  • 资助金额:
    $ 17万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of a real-time evaluation method using an AI-based image processing system in liver tumor ablaition
基于人工智能的图像处理系统开发肝脏肿瘤消融实时评估方法
  • 批准号:
    23K11923
  • 财政年份:
    2023
  • 资助金额:
    $ 17万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of Hard Real-Time Recognition Technologies With Deadline-driven AI Accelerators
利用截止日期驱动的人工智能加速器开发硬实时识别技术
  • 批准号:
    23H03477
  • 财政年份:
    2023
  • 资助金额:
    $ 17万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了